Clinical pharmacologic evaluation of the antiatherosclerotic agent, pyridinolcarbamate. A double-blind crossover trial in the treatment of atherosclerosis obliterans - Concepedia

Concepedia

Publication | Closed Access

Clinical pharmacologic evaluation of the antiatherosclerotic agent, pyridinolcarbamate. A double-blind crossover trial in the treatment of atherosclerosis obliterans

27

Citations

14

References

1970

Year

Takio Shimamoto, Toshiyuki Atsumi, Sekiya Yamashita, Takeshi Motomiya, N Isokane, Tadao Ishioka, Akira Sakuma

American Heart Journal

Clinical Pharmacologic EvaluationCardiovascular DiseaseMedicinePharmacotherapyArterial DiseaseAtherosclerosis ObliteransPharmacologyAtherosclerosisDyslipidemiaDouble-blind Crossover Trial

References

	Year	Citations

Page 1